Chaoju Eye Care Holdings Ltd. (HK:2219) has released an update.
Chaoju Eye Care Holdings Ltd., through its subsidiary Chaoju Medical Technology, has subscribed to new structured deposit products with the Bank of China, totaling RMB150 million. These deposits, guaranteed in principal with low risk and an expected annualized return of 1.5% to 2.9%, are linked to the EUR/USD exchange rate. The investment, funded by the group’s surplus cash, is classified as a discloseable transaction under the Listing Rules, meaning it requires reporting and announcement but not shareholder approval.
For further insights into HK:2219 stock, check out TipRanks’ Stock Analysis page.
